Key result
Ultrathin-strut EES at coronary bends linked to focal in-stent restenosis and stent deformation.
Case Report (n=1)
Ultrathin-strut drug-eluting stents may be prone to deformation and in-stent restenosis when deployed at coronary bends due to poor radial strength.
Answers are grounded in this paper and cite their sources.
Stent deformation at bends may drive focal restenosis; leaves open optimal stent selection in angulated lesions.
We describe a 64-year-old male who underwent percutaneous coronary intervention of an angulated right coronary artery lesion using overlapping ultrathin-strut everolimus-eluting stents. Although the initial angiographic result was optimal, the patient developed recurrent angina at six months, and repeat angiography revealed focal in-stent restenosis localised to the coronary bends with fluoroscopic evidence of stent deformation. The overlap segment was relatively spared. Repeat intervention with a conventional thin-strut DES resulted in excellent clinical and angiographic outcomes at one-year follow-up. This case underscores the importance of unfavourable outcome of ultrathin strut DES at coronary bends, possibly secondary to poor radial strength leading to stent deformation and in-stent restenosis.
No takes yet. Share an insight, caveat, or question.
Panda et al. (2026) conducted a case report in Angulated right coronary artery lesion (n=1). Ultrathin-strut everolimus-eluting stents was evaluated on Focal in-stent restenosis and stent deformation. Ultrathin-strut everolimus-eluting stents implanted at a coronary bend led to focal in-stent restenosis and stent deformation at six months, possibly due to poor radial strength.
Synapse has enriched 10 related papers. Consider them for comparative context: